Methods to Evaluate the Antiobesity Effects of Medicinal Plants Using Enzyme Assays

被引:2
作者
Bandara, Subhani [1 ]
Devereaux, Shelby [1 ]
Weerasooriya, Aruna [1 ]
机构
[1] Prairie View A&M Univ, Cooperat Agr Res Ctr, Prairie View, TX 77446 USA
来源
OBESITIES | 2023年 / 3卷 / 01期
关键词
obesity; enzyme assay method; medicinal plants; enzyme inhibitors; pancreatic lipase; cholesterol esterase; alpha-amylase; alpha-glucosidase; PANCREATIC LIPASE INHIBITORS; ALPHA-AMYLASE; CHOLESTEROL ESTERASE; DIABETES-MELLITUS; OBESITY; ABSORPTION; EXTRACTS; ACIDS;
D O I
10.3390/obesities3010003
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Obesity is a chronic disease affecting both adults and children worldwide. One major cause of obesity is high-calorie intake due to overconsumption of foods rich in fat and carbohydrates. Hence, obesity can be controlled by controlling the diet and by other lifestyle changes that increase energy expenditure. However, this is not always possible for individuals who are already overweight and suffering from other diseases. Therefore, certain drugs have been developed to assist with weight reduction. One major avenue for drug development involves the inhibition of enzymes that break down fat and carbohydrates from the diet. This can reduce the bioavailability and absorption of dietary lipids and carbohydrates, allowing for the management of obesity. Although there are synthetic drugs available on the market to inhibit these enzymes, plant-based natural drugs may provide a better alternative to treat obesity due to fewer side effects and a lower cost. In this review, different methods that can be used to screen medicinal plant extracts for inhibitors of those digestive enzymes and certain limitations of those methods are discussed. Currently, there is limited research on the effects of varying conditions on enzyme assays, and this is an area that can be addressed in future research.
引用
收藏
页码:13 / 35
页数:23
相关论文
共 56 条
  • [41] Absorption and distribution of dietary fatty acids from different sources
    Ramírez, M
    Amate, L
    Gil, A
    [J]. EARLY HUMAN DEVELOPMENT, 2001, 65 : S95 - S101
  • [42] Flavonoids as antiobesity agents: A review
    Rufino, Ana T.
    Costa, Vera M.
    Carvalho, Felix
    Fernandes, Eduarda
    [J]. MEDICINAL RESEARCH REVIEWS, 2021, 41 (01) : 556 - 585
  • [43] Metabolic and Epigenetics Action Mechanisms of Antiobesity Medicinal Plants and Phytochemicals
    Saad, Bashar
    Ghareeb, Bilal
    Kmail, Abdalsalam
    [J]. EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2021, 2021
  • [44] Evaluation of Antioxidant, Antidiabetic and Antiobesity Potential of Selected Traditional Medicinal Plants
    Sekhon-Loodu, Satvir
    Rupasinghe, H. P. Vasantha
    [J]. FRONTIERS IN NUTRITION, 2019, 6
  • [45] Aqueous extract of Psidium guajava']java leaves: phenolic compounds and inhibitory potential on digestive enzymes
    Simao, Anderson A.
    Marques, Tamara R.
    Marcussi, Silvana
    Correa, Angelita D.
    [J]. ANAIS DA ACADEMIA BRASILEIRA DE CIENCIAS, 2017, 89 (03): : 2155 - 2165
  • [46] Assessing the In Vitro Inhibitory Effects on Key Enzymes Linked to Type-2 Diabetes and Obesity and Protein Glycation by Phenolic Compounds of Lauraceae Plant Species Endemic to the Laurisilva Forest
    Spinola, Vitor
    Castilho, Paula C.
    [J]. MOLECULES, 2021, 26 (07):
  • [47] Comparison of Metabolites Variation and Antiobesity Effects of Fermented versus Nonfermented Mixtures of Cudrania tricuspidata, Lonicera caerulea, and Soybean According to Fermentation In Vitro and In Vivo
    Suh, Dong Ho
    Jung, Eun Sung
    Park, Hye Min
    Kim, Seung Hyung
    Lee, Sarah
    Jo, Yang Hee
    Lee, Mi Kyeong
    Jung, Gayoung
    Do, Seon-Gil
    Lee, Choong Hwan
    [J]. PLOS ONE, 2016, 11 (02):
  • [48] The role of lipid and carbohydrate digestive enzyme inhibitors in the management of obesity: a review of current and emerging therapeutic agents
    Tucci, Sonia A.
    Boyland, Emma J.
    Halford, Jason C. G.
    [J]. DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2010, 3 : 125 - 143
  • [49] Natural Products as α-Amylase and α-Glucosidase Inhibitors and their Hypoglycaemic Potential in the Treatment of Diabetes: An Update
    Tundis, R.
    Loizzo, M. R.
    Menichini, F.
    [J]. MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2010, 10 (04) : 315 - 331
  • [50] In vitro alpha-amylase, alpha-glucosidase, lipase inhibitory and cytotoxic activities of tuber extracts of Kedrostis africana (L.) Cogn
    Unuofin, Jeremiah Oshiomame
    Otunola, Gloria Aderonke
    Afolayan, Anthony Jide
    [J]. HELIYON, 2018, 4 (09):